AQR Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04B Sell
8,628,486
-2,620,877
-23% -$303M 0.48% 22
2025
Q4
$1.18B Buy
11,249,363
+591,264
+6% +$55.5M 0.62% 15
2025
Q3
$851M Buy
10,658,099
+1,870,827
+21% +$154M 0.55% 18
2025
Q2
$690M Buy
8,787,272
+1,029,454
+13% +$81.8M 0.57% 14
2025
Q1
$691M Buy
7,757,818
+2,380,066
+44% +$222M 0.71% 10
2024
Q4
$533M Buy
5,377,752
+2,354,723
+78% +$243M 0.69% 11
2024
Q3
$343M Buy
3,023,029
+811,759
+37% +$96.4M 0.47% 25
2024
Q2
$274M Sell
2,211,270
-26,990
-1% -$3.48M 0.42% 33
2024
Q1
$295M Sell
2,238,260
-96,821
-4% -$11.9M 0.5% 26
2023
Q4
$254M Sell
2,335,081
-212,423
-8% -$22M 0.48% 32
2023
Q3
$262M Sell
2,547,504
-359,583
-12% -$38.8M 0.54% 24
2023
Q2
$332M Buy
2,907,087
+94,248
+3% +$10.7M 0.71% 12
2023
Q1
$298M Sell
2,812,839
-299,967
-10% -$32.4M 0.66% 16
2022
Q4
$345M Sell
3,112,806
-814,166
-21% -$83.2M 0.79% 11
2022
Q3
$338M Sell
3,926,972
-188,449
-5% -$16.8M 0.82% 12
2022
Q2
$375M Buy
4,115,421
+508,923
+14% +$45.1M 0.85% 10
2022
Q1
$296M Sell
3,606,498
-275,465
-7% -$21.7M 0.56% 23
2021
Q4
$298M Sell
3,881,963
-967,353
-20% -$77M 0.54% 27
2021
Q3
$364M Sell
4,849,316
-60,654
-1% -$4.61M 0.68% 19
2021
Q2
$380M Sell
4,909,970
-1,858,673
-27% -$138M 0.66% 19
2021
Q1
$495M Sell
6,768,643
-329,966
-5% -$24.3M 0.81% 17
2020
Q4
$547M Sell
7,098,609
-251,668
-3% -$19.2M 0.97% 11
2020
Q3
$576M Sell
7,350,277
-524,173
-7% -$41.1M 0.97% 12
2020
Q2
$574M Sell
7,874,450
-497,236
-6% -$37.4M 0.93% 11
2020
Q1
$605M Buy
8,371,686
+321,098
+4% +$25.2M 1.02% 12
2019
Q4
$696M Buy
8,050,588
+340,916
+4% +$28M 0.79% 13
2019
Q3
$619M Sell
7,709,672
-4,201,993
-35% -$337M 0.73% 14
2019
Q2
$953M Sell
11,911,665
-1,205,837
-9% -$92.3M 1.06% 8
2019
Q1
$1.04B Sell
13,117,502
-589,049
-4% -$44.1M 1.1% 7
2018
Q4
$999M Buy
13,706,551
+5,020,441
+58% +$354M 1.16% 4
2018
Q3
$588M Buy
8,686,110
+1,882,585
+28% +$120M 0.56% 36
2018
Q2
$394M Sell
6,803,525
-2,853,781
-30% -$161M 0.4% 58
2018
Q1
$507M Sell
9,657,306
-632,371
-6% -$34.2M 0.55% 34
2017
Q4
$552M Sell
10,289,677
-1,562,119
-13% -$86.6M 0.58% 33
2017
Q3
$724M Buy
11,851,796
+3,134,810
+36% +$190M 0.86% 7
2017
Q2
$533M Buy
8,716,986
+179,355
+2% +$10.9M 0.71% 13
2017
Q1
$518M Buy
8,537,631
+1,636,822
+24% +$99.3M 0.69% 9
2016
Q4
$388M Buy
6,900,809
+1,533,889
+29% +$89.8M 0.53% 31
2016
Q3
$320M Buy
5,366,920
+858,818
+19% +$50.2M 0.49% 32
2016
Q2
$248M Buy
4,508,102
+60,132
+1% +$3.2M 0.44% 41
2016
Q1
$225M Sell
4,447,970
-365,015
-8% -$17.9M 0.4% 48
2015
Q4
$243M Sell
4,812,985
-2,412,296
-33% -$122M 0.42% 43
2015
Q3
$341M Sell
7,225,281
-715,150
-9% -$38M 0.68% 24
2015
Q2
$431M Buy
7,940,431
+89,748
+1% +$5.03M 0.86% 10
2015
Q1
$431M Buy
7,850,683
+6,415
+0.1% +$363K 0.98% 5
2014
Q4
$425M Buy
7,844,268
+3,209,599
+69% +$179M 0.89% 6
2014
Q3
$262M Buy
4,634,669
+1,068,661
+30% +$60M 0.72% 11
2014
Q2
$197M Buy
3,566,008
+541,188
+18% +$29.5M 0.53% 23
2014
Q1
$164M Buy
3,024,820
+1,503,497
+99% +$77.9M 0.49% 32
2013
Q4
$72.7M Sell
1,521,323
-630,999
-29% -$28.8M 0.22% 116
2013
Q3
$97.8M Sell
2,152,322
-1,349,221
-39% -$61.6M 0.34% 54
2013
Q2
$155M Buy
+3,501,543
New +$156M 0.55% 24

Other funds holding MRK

AQR Capital Management's MRK Position: Q1 2026 in Review

AQR Capital Management reduced its Merck (MRK) stake by 23% in Q1 2026, selling an estimated $303M and leaving 8,628,486 shares worth $1.04B. The position accounts for 0.48% of the portfolio, ranked #22.

AQR Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.18B in Q4 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • AQR Capital Management held 8,628,486 shares of Merck worth $1.04B as of Q1 2026.
  • AQR Capital Management sold 2,620,877 Merck shares in Q1 2026, an estimated $303M.
  • Merck made up 0.48% of AQR Capital Management's portfolio in Q1 2026, its #22 holding.
  • AQR Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • AQR Capital Management's Merck position peaked at $1.18B in Q4 2025.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.